BioNTech SE — Investor Relations & Filings
BioNTech SE is a global biotechnology company pioneering novel therapies for cancer and infectious diseases. The company leverages its deep expertise in immunology to develop a diverse portfolio of therapeutic platforms. Its oncology pipeline includes mRNA-based cancer immunotherapies, next-generation immunomodulators, and targeted therapies, with a strategy focused on creating synergistic combinations. In infectious diseases, BioNTech applies its proprietary mRNA technology to develop vaccines, most notably co-developing the first authorized mRNA-based vaccine for COVID-19. The company's core mission is to translate scientific research into innovative treatments that harness the power of the immune system to improve or establish new standards of care for patients globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - BioNTech SE (0001776985) (Filer) | 2026-04-13 | English | |
| 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | |
| 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | |
| 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | |
| 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | |
| 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 34410564 | 6-K - BioNTech SE (0001776985) (Filer) | 2026-04-13 | English | ||
| 33043274 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | ||
| 33043267 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | ||
| 33043266 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | ||
| 33043268 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | ||
| 33043221 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | ||
| 33043218 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | ||
| 33043216 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-25 | English | ||
| 32980076 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-18 | English | ||
| 32980070 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-18 | English | ||
| 32979862 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-18 | English | ||
| 32979841 | 3 - BioNTech SE (0001776985) (Issuer) | 2026-03-18 | English | ||
| 31669917 | 6-K Filing | 2026-01-28 | English | ||
| 13180598 | 6-K | 2026-01-14 | English | ||
| 13180599 | 6-K | 2026-01-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
BioNTech SE via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30236/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30236 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30236 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30236 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30236}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioNTech SE (id: 30236)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.